Christopher Moxham's Net Worth

$754 Thousand

Estimate Recalculated May 9, 2024 03:12PM EST

Who is Christopher Moxham?

Christopher Moxham does not have any significant net worth to report based on the numbers we have. This is based on reported shares in Fulcrum Therapeutics, Inc..

SEC CIK

Christopher Moxham's CIK is 0001843784

Past Insider Trading and Trends

2021 was Christopher Moxham's most active year for acquiring shares with 3 total transactions. Christopher Moxham's most active month to acquire stocks was the month of July. 2021 was Christopher Moxham's most active year for disposing of shares, totalling 4 transactions. Christopher Moxham's most active month to dispose stocks was the month of July. 2021 saw Christopher Moxham paying a total of $405,994.40 for 151,785 shares, this is the most they've acquired in one year. In 2021 Christopher Moxham cashed out on 103,570 shares for a total of $911,416.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Fulcrum Therapeutics, Inc. (FULC) Snapshot price: $7.995

Chief Scientific Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
$12.67
-$505,421.60
31.07K
Scheduled
Aug 10
Form 4
—
0
—
—
0
Feb 8
Form 3
—
0
—
—
0
No matching records found